Get Free Delivery With No Minimum Order

MUCOSOLVAN FORTE SYRUP 250ML
- Sku : I-025215
Key features
Mucosolvan Forte Syrup 250 ml is an oral liquid formulation containing ambroxol hydrochloride 6 mg/ml. Ambroxol acts as a mucolytic/secretolytic, reducing mucus viscosity, enhancing mucociliary clearance and stimulating surfactant and ciliary activity to facilitate expectoration. It is indicated for secretolytic therapy in acute and chronic bronchopulmonary conditions with abnormal mucus secretion and impaired mucus transport, such as acute or chronic bronchitis, tracheobronchitis and bronchiectasis. Available OTC in a 250 ml syrup.- Brand: MUCOSOLVAN
- Active Ingredient: AMBROXOL HYDROCHLORIDE 6mg/ml
- Strength: 6mg/ml
- Dosage Form: Oral liquid
- Pack Size: 250 ml
- Route: Oral use
- Prescription Status: OTC
- Therapeutic Class: Respiratory
- Pharmacological Group: Cough & Cold Preparations
- Drug Class: Mucolytic/secretolytic agent (ambroxol; benzylamine derivative).
- Manufacturer: DELPHARM REIMS S.A.S
- Country of Origin: France
- SFDA Registration No.: 906245397
- Shelf Life: 36 months
- Storage: do not store above 30°c
- Symptom Target: Cough
- Sedating: No
Indications
Approved Uses
Secretolytic (mucolytic) therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport (e.g., acute/chronic bronchitis, tracheobronchitis, bronchiectasis).
Dosage & Administration
How to Take
Shake well before use; measure the dose with an appropriate measuring device; take orally with or without food (taking after meals may reduce gastrointestinal upset); maintain adequate fluid intake.
How to Prepare
N/A - ready-to-use oral liquid (no reconstitution required).
Side Effects
Common Side Effects
Common: gastrointestinal effects (nausea, vomiting, diarrhea, dyspepsia/abdominal pain) and taste disturbance; dry mouth/throat can occur.
Safety & Warnings
Contraindications
Contraindicated in patients with hypersensitivity to ambroxol hydrochloride or any excipients; hereditary fructose intolerance is a contraindication if the syrup contains sorbitol/fructose sources.
Age Restriction
Not recommended in children <2 years unless under medical supervision/medical advice.
Drug Interactions
Drug Interactions
Avoid/Use caution with concomitant antitussives (e.g., codeine, dextromethorphan) due to impaired mucus clearance; ambroxol may increase antibiotic concentrations in bronchopulmonary secretions (e.g., amoxicillin, cefuroxime, erythromycin, doxycycline) without a major harmful interaction.
Special Populations
Pregnancy
Consult Doctor
Breastfeeding
Consult Doctor
Liver Impairment
No routine adjustment in mild-moderate hepatic impairment; in severe hepatic impairment use with caution and consider dose reduction/longer intervals under medical supervision.
Storage & Patient Advice
Preparation Instructions
N/A - ready-to-use oral liquid (no reconstitution required).
Missed Dose
Take the missed dose as soon as remembered; if it is close to the next scheduled dose, skip the missed dose and resume the regular schedule; do not double doses.
Overdose
Overdose may cause GI symptoms (nausea, vomiting, diarrhea), hypersalivation, and possible hypotension; management is supportive/symptomatic, consider decontamination if very recent large ingestion, and seek urgent medical attention.
Patient Counseling
Explain it loosens mucus to make coughing up phlegm easier; take as directed and measure doses accurately (shake bottle before use); can be taken with or without food; maintain good hydration; avoid combining with cough suppressants (e.g., dextromethorphan/codeine) unless advised; stop and seek urgent care if rash, blistering, or peeling occurs (SCAR risk); seek medical advice if symptoms persist/worsen or if used beyond ~4-5 days without improvement; store below 30°C and keep out of reach of children.
Pharmacology
Mechanism of Action
Ambroxol is a mucolytic/secretolytic that reduces mucus viscosity and enhances mucociliary clearance; it also stimulates surfactant production and may increase ciliary activity, facilitating expectoration.
Onset of Action
Approximately 30 minutes after oral administration.
Bioavailability
Approximately 70-80% (about 79% for immediate-release oral formulations).
Excretion
Primarily renal excretion, mostly as metabolites (majority of dose recovered in urine; only a small fraction in feces).
Protein Binding
Approximately 80-90%
Product Information
Available Dosage Forms
For ambroxol (brand family): oral syrup/oral solution, tablets, prolonged-release capsules, oral drops/solution, inhalation solution; some markets also have lozenges and parenteral forms (injection/infusion).
Composition per Dose
Each 5ml: 30mg ambroxol hydrochloride (equivalent to 6mg/ml)
Generic Availability
Yes
Symptom Target
Cough
Sedating
No
Legal Disclaimer - Al Mujtama Pharmacy The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment. Al Mujtama Pharmacy assumes no legal or medical liability for: Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist Any discrepancy between the information provided and the product's package insert or SFDA guidelines Any misuse of medication resulting from personal interpretation of the content displayed Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication. By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation. Your health is a trust - always consult your doctor first.-1744229570.gif)





